List of Studies ( Metabolite:Tetrahydrofuran)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004200 | AN006985 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST004200 | AN006986 | untargeted metabolomics in serum of microplastics exposed mice - Untargeted LC/MS | Blood | Mouse | Environmental exposure | University of Washington | LC-MS |
| ST003295 | AN005396 | TRACING DIVERSION OF WASTE DERIVED CARBON TO OMEGA FATTY ACID: A COMPARATIVE METABOLOMICS APPROACH | Cultured cells | Aurantiochytrium limacinum | Lulea University of Technology | GC-MS | |
| ST002500 | AN004107 | Plasma metabolomic signatures from patients following high-dose total body irradiation | Blood | Human | Radiation exposure | Soochow University | GC-MS/LC-MS |
| ST000549 | AN000839 | Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors | Blood | Mouse | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000670 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000666 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
